Spark Therapeutics, a drug developer spinout of Children's Hospital of Philadelphia, is set to go public on Nasdaq.

The molecular profiling company, backed by Novo, GlaxoSmithKline and Merck, is seeking to float on Nasdaq.

The Kraft-backed neuromuscular treatment developer is seeking $60m, which will be invested in research and marketing.

Kaiser Permanente has joined the behaviour analytics company's shareholders, as it raised money that took its overall funding to almost $28m.

The Fosun Pharma-backed medical imaging company intends to raise the cash through an initial public offering and concurrent private placement.

The Physio-Control-backed company, which develops cooling products to treat brain injury, has filed for a $13.8m initial public offering.

Assurex, the developer of a testing system for mental health disorders, has raised new funding from backers including two healthcare providers.

The insulin pump developer, backed by Novo and Lundbeck, will also seek $17.1m from a concurrent private placement.

Cardiovascular imaging technology developer Infraredx, which is backed by Nipro and Intrepid Maritime, is looking to advance trials for its catheter product.